Alumis Inc.
ALMS • XNAS
Alumis Inc. is a pharmaceutical preparations company trading on XNAS, led by CEO Martin Babler, with a market cap of $3.2B.
CEOMartin Babler
Next Earnings
Upcoming earnings announcement for Alumis Inc.
Date
Wednesday, May 13, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.83
Revenue Estimate
$3.0M
Earnings History
Past 7 earnings reports for Alumis Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 19, 2026 | Q4 2025 | -$0.94Est: -$0.97 | +3.1% | $1.9MEst: $2.9M | -33.7% |  10-K |
| Nov 13, 2025 | Q3 2025 | -$1.06Est: -$0.97 | -9.3% | $2.1MEst: $3.7M | -43.9% | 10-Q |
| Aug 13, 2025 | Q2 2025 | -$1.27Est: -$1.28 | +0.8% | $2.7MEst: $3.3M | -18.1% | 10-Q |
| May 14, 2025 | Q1 2025 | -$1.82Est: -$0.91 | -100.0% | $17.4M | — | 10-Q |
| Mar 19, 2025 | Q4 2024 | -$1.74Est: -$1.44 | -20.8% | - | — | 10-K/A |
| Nov 13, 2024 | Q3 2024 | -$1.73Est: -$4.50 | +61.6% | - | — | 10-Q |
| Aug 13, 2024 | Q2 2024 | -$23.10 | — | - | — | 10-Q |